Emma Hackett, a 54-year-old resident of West Sussex, lost more than two stone after using a dietary supplement called Elcella alongside significant lifestyle changes. While the product is marketed as a natural alternative to prescription weight-loss medications, medical experts warn that its efficacy remains unproven.
The £160-a-month promise of Elcella's oil blend
Developed by scientists at Queen Mary University of London, Elcella is positioned as a non-prescription alternative for those wary of the side effects associated with pharmaceutical interventions. According to the report, the supplement costs £160 per month and consists of a specific combination of linseed,coconut, and MCT oils. The goal of this blend is to stimulate the gut to release peptide YY and GLP-1, hormones that signal fullness to the brain to reduce overall food intake.
Dr. Madusha Peiris of Queen Mary University of London argues that obesity often stems from a diminished ability to recognize satiety. By triggering these specific hormones, Elcella aims to help users naturally eat less. However, the mechanism is a simplified version of the biological pathways targeted by high-potency prescription drugs, and the supplement is sold as a food product rather than a regulated medicine.
Emma Hackett's journey from 14 stone to 11st 12lb
The case of Emma Hackett provides a compelling but scientifically ambiguous example of the supplement's potential. after a health check in September revealed a BMI of 32.6, the mother-of-four began taking Elcella in November. While she noted little change initially, she eventually saw her weight drop from 14 stone to a current weight of 11st 12lb. this transformation, however, coincided with a rigorous new health regimen.
As the report says, Emma Hackett simultaneously adopted a diet focused on pulses, beans, and oat bran while eliminating ultra-processed foods and habitual snacking on crisps. She also integrated strength training twice weekly and walking two miles several times a week. Because these lifestyle shifts occurred alongside the supplement use, it is impossible to isolate Elcella as the primary driver of her weight loss.
The gap between Elcella and the 1.6 million users of prescription GLP-1s
The rise of Elcella reflects a broader trend of consumers seeking "natural" alternatives to the pharmaceutical boom led by drugs like Wegovy and Mounjaro . In Britain alone, an estimated 1.6 million adults are using prescription weight-loss medications. Unlike these drugs, which act directly on hormone receptors and are backed by massive clinical trials, Elcella lacks the same level of rigorous, independent validation.
The appetite-suppressing trend has created a lucrative market for supplements that mimic the "GLP-1 effect." However, the medical community distinguishes between a food supplement and a prescription drug based on the evidence of sustained, significant weight loss. while Emma Hackett credits the supplement with helping her break old habits, the lack of gold-standard trials makes it difficult to recommend Elcella as a reliable medical tool for obesity.
Why the 1st 1lb average loss lacks gold-standard proof
Internal claims from Elcella suggest that users in their studies lost an average of 1st 1lb over 12 weeks and reduced calorie intake by 18 per cent. While these numbers are positive, they pale in comparison to the dramatic results often seen with prescription GLP-1 agonists. Furthermore, the source notes a critical detail in Emma Hackett's story: she stopped taking Elcella in May but continued to lose weight through July.
This raises a pivotal question: if the weight loss continued after the supplement was removed, was the product ever the catalyst, or was it merely a psychological trigger for her lifestyle changes? Until Elcella undergoes large-scale, independent clinical trials , the medical community remains skeptical of claims that a blend of oils can replicate the power of pharmaceutical weight-loss interventions.
Comments 0